Samuel Broder

30.9k total citations · 3 hit papers
121 papers, 12.3k citations indexed

About

Samuel Broder is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Samuel Broder has authored 121 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 50 papers in Virology and 47 papers in Immunology. Recurrent topics in Samuel Broder's work include HIV/AIDS drug development and treatment (53 papers), HIV Research and Treatment (50 papers) and T-cell and Retrovirus Studies (32 papers). Samuel Broder is often cited by papers focused on HIV/AIDS drug development and treatment (53 papers), HIV Research and Treatment (50 papers) and T-cell and Retrovirus Studies (32 papers). Samuel Broder collaborates with scholars based in United States, Malaysia and Belgium. Samuel Broder's co-authors include Hiroaki Mitsuya, Robert Yarchoan, Thomas A. Waldmann, Robert C. Gallo, David G. Johns, Rose V. Thomas, Charles E. Myers, Jan Balzarini, Werner J. Pichler and Erik De Clercq and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Samuel Broder

121 papers receiving 11.5k citations

Hit Papers

ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITO... 1986 2026 1999 2012 1986 1990 1989 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Broder United States 57 5.8k 5.1k 3.0k 3.0k 2.8k 121 12.3k
S Broder United States 46 4.7k 0.8× 4.1k 0.8× 2.7k 0.9× 3.4k 1.1× 2.0k 0.7× 96 10.8k
Jan Desmyter Belgium 52 4.9k 0.8× 4.1k 0.8× 2.0k 0.7× 2.3k 0.8× 2.9k 1.0× 207 10.2k
Kent J. Weinhold United States 50 4.2k 0.7× 6.5k 1.3× 2.6k 0.9× 4.0k 1.3× 2.4k 0.8× 170 10.1k
Masanori Baba Japan 62 6.9k 1.2× 5.9k 1.2× 5.0k 1.7× 3.2k 1.1× 3.3k 1.2× 372 16.0k
Emilio A. Emini United States 58 9.2k 1.6× 9.7k 1.9× 4.4k 1.5× 3.0k 1.0× 4.9k 1.7× 176 18.0k
Jean‐Claude Chermann France 31 4.0k 0.7× 6.0k 1.2× 1.4k 0.4× 4.0k 1.3× 2.2k 0.8× 110 9.8k
Louis E. Henderson United States 49 2.5k 0.4× 4.4k 0.9× 4.5k 1.5× 1.9k 0.6× 1.5k 0.5× 94 8.9k
Willy Rozenbaum France 43 5.0k 0.9× 5.8k 1.2× 1.2k 0.4× 2.7k 0.9× 3.1k 1.1× 169 11.0k
C. Dauguet France 25 3.3k 0.6× 4.9k 1.0× 1.5k 0.5× 3.1k 1.0× 2.4k 0.8× 44 8.2k
Rudi Pauwels Belgium 63 9.2k 1.6× 8.1k 1.6× 4.4k 1.4× 1.4k 0.5× 3.4k 1.2× 145 14.9k

Countries citing papers authored by Samuel Broder

Since Specialization
Citations

This map shows the geographic impact of Samuel Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Broder more than expected).

Fields of papers citing papers by Samuel Broder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Broder. The network helps show where Samuel Broder may publish in the future.

Co-authorship network of co-authors of Samuel Broder

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Broder. A scholar is included among the top collaborators of Samuel Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Broder. Samuel Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillett, Cheryl, Paul Cane, Lauren Kam-Morgan, et al.. (2009). A Single-Tube Quantitative Assay for mRNA Levels of Hormonal and Growth Factor Receptors in Breast Cancer Specimens. Journal of Molecular Diagnostics. 11(2). 117–130. 17 indexed citations
2.
Broder, Samuel. (2009). The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Research. 85(1). 1–18. 340 indexed citations
3.
Broder, Samuel, Stephen L. Hoffman, & Peter J. Hotez. (2002). Cures for the Third World's problems. EMBO Reports. 3(9). 806–812. 18 indexed citations
4.
Broder, Samuel & J. Craig Venter. (2000). Whole genomes: the foundation of new biology and medicine. Current Opinion in Biotechnology. 11(6). 581–585. 18 indexed citations
5.
Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1993). Challenges in the therapy of HIV infection. Trends in Pharmacological Sciences. 14(5). 196–202. 14 indexed citations
6.
Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1993). Challenges in the therapy of HIV infection. Immunology Today. 14(6). 303–309. 29 indexed citations
7.
Sei, Shizuko, Robert Yarchoan, Seiji Kageyama, et al.. (1992). Plasma HIV-1 Viremia in HIV-1 Infected Individuals Assessed by Polymerase Chain Reaction. AIDS Research and Human Retroviruses. 8(7). 1263–1270. 65 indexed citations
8.
Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1992). The Immunology of HIV Infection: Implications for Therapy. AIDS Research and Human Retroviruses. 8(6). 1023–1031. 5 indexed citations
9.
Perno, Carlo Federico, David A. Cooney, Michael J. Currens, et al.. (1990). Ability of Anti-HIV Agents to Inhibit HIV Replication in Monocyte/Macrophages or U937 Monocytoid Cells Under Conditions of Enhancement by GM-CSF or Anti-HIV Antibody. AIDS Research and Human Retroviruses. 6(8). 1051–1055. 22 indexed citations
10.
Aoki, Shizuko, Robert Yarchoan, Rose V. Thomas, et al.. (1990). Quantitative Analysis of HIV-1 Proviral DNA in Peripheral Blood Mononuclear Cells from Patients with AIDS or ARC: Decrease of Proviral DNA Content Following Treatment with 2′,3′-Dideoxyinosine (ddI). AIDS Research and Human Retroviruses. 6(11). 1331–1339. 54 indexed citations
11.
Márquez, Víctor E., Christopher K. H. Tseng, Hiroaki Mitsuya, et al.. (1990). Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. Journal of Medicinal Chemistry. 33(3). 978–985. 183 indexed citations
12.
Broder, Samuel, et al.. (1990). Antiretroviral Therapy in AIDS. Annals of Internal Medicine. 113(8). 604–618. 49 indexed citations
13.
Majumdar, C., Cy A. Stein, Jack S. Cohen, Samuel Broder, & Samuel H. Wilson. (1989). Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. Biochemistry. 28(3). 1340–1346. 160 indexed citations
14.
Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1989). Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infection. The American Journal of Medicine. 87. 191–200. 1 indexed citations
15.
Capon, Daniel J., Steven M. Chamow, Joyce Mordenti, et al.. (1989). Designing CD4 immunoadhesins for AIDS therapy. Nature. 337(6207). 525–531. 508 indexed citations breakdown →
16.
Balzarini, Jan, Piet Herdewijn, Rudi Pauwels, Samuel Broder, & Erik De Clercq. (1988). ga,β- and β,γ-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Biochemical Pharmacology. 37(12). 2395–2403. 22 indexed citations
17.
Broder, Samuel. (1987). AIDS, modern concepts and therapeutic challenges. DigitalGeorgetown (Georgetown University Library). 46 indexed citations
18.
19.
Pichler, Werner J., Lawrence G. Lum, & Samuel Broder. (1978). Fc-Receptors on Human T Lymphocytes. The Journal of Immunology. 121(4). 1540–1548. 105 indexed citations
20.
Broder, Samuel, David G. Poplack, Jacqueline Whang‐Peng, et al.. (1978). Characterization of a Suppressor-Cell Leukemia. New England Journal of Medicine. 298(2). 66–72. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026